Drug Profile
Ziprasidone extended release
Alternative Names: ziprasidone once-dailyLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Lipocine
- Class Antipsychotics; Mood stabilisers; Piperazines; Thiazoles
- Mechanism of Action Dopamine D2 receptor antagonists; Serotonin 5-HT2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bipolar disorders; Schizophrenia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Bipolar-disorders in USA (PO, Controlled release)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Schizophrenia in USA (PO, Controlled release)
- 12 Nov 2008 Phase-I clinical trials in Bipolar disorders in USA (PO)